AIQ |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3 GBX | 0.00% |
|
0.00% | -40.00% |
| Feb. 28 | EARNINGS: Hutchmed revenue surges, Craven House's loss widens | AN |
| Feb. 28 | AIQ Limited Reports Earnings Results for the Full Year Ended October 31, 2023 | CI |
Valuation
| Fiscal Period: October | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 12.7 | 14.26 | 12.3 | 9.714 | 8.095 | 4.857 |
| Enterprise Value (EV) 1 | 8.597 | 10.55 | 10.75 | 9.302 | 8.037 | 5.222 |
| P/E ratio | -16.6 x | -28.3 x | -3.12 x | -8.13 x | -12.6 x | -9.23 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | 79,564,278 x | 157,026,138 x | 16,242,546 x | 23,440,362 x |
| EV / Revenue | - | - | 69,511,332 x | 150,364,176 x | 16,125,276 x | 25,199,721 x |
| EV / EBITDA | - | - | -8,130,859 x | -9,328,771 x | -16,657,534 x | -11,770,401 x |
| EV / FCF | 52.2 x | -58.8 x | -10.2 x | -14.6 x | -37.5 x | -27.4 x |
| FCF Yield | 1.91% | -1.7% | -9.8% | -6.85% | -2.67% | -3.65% |
| Price to Book | 3.42 x | 4.44 x | 6.6 x | 14.2 x | 150 x | -10.3 x |
| Nbr of stocks (in thousands) | 51,839 | 51,839 | 64,761 | 64,761 | 64,761 | 64,761 |
| Reference price 2 | 0.2450 | 0.2750 | 0.1900 | 0.1500 | 0.1250 | 0.0750 |
| Announcement Date | 2/22/19 | 1/24/20 | 4/30/21 | 2/28/22 | 2/28/23 | 2/28/24 |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: October | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales | - | - | 0.1546 | 0.0619 | 0.4984 | 0.2072 |
| EBITDA | - | - | -1.322 | -0.9971 | -0.4825 | -0.4436 |
| EBIT 1 | -0.3524 | -0.4523 | -1.329 | -1.023 | -0.5089 | -0.447 |
| Operating Margin | - | - | -859.1% | -1,653.12% | -102.1% | -215.71% |
| Earnings before Tax (EBT) 1 | -0.6039 | -0.5036 | -4.131 | -1.193 | -0.6409 | -0.5032 |
| Net income 1 | -0.6039 | -0.5036 | -3.638 | -1.195 | -0.6409 | -0.5263 |
| Net margin | - | - | -2,352.16% | -1,931.57% | -128.6% | -253.98% |
| EPS 2 | -0.0147 | -0.009714 | -0.0608 | -0.0185 | -0.009896 | -0.008126 |
| Free Cash Flow 1 | 0.1645 | -0.1794 | -1.053 | -0.6376 | -0.2144 | -0.1904 |
| FCF margin | - | - | -681.12% | -1,030.64% | -43.01% | -91.9% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 2/22/19 | 1/24/20 | 4/30/21 | 2/28/22 | 2/28/23 | 2/28/24 |
1GBP in Million2GBP
Estimates
Balance Sheet Analysis
| Fiscal Period: October | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | 0.36 |
| Net Cash position 1 | 4.1 | 3.7 | 1.55 | 0.41 | 0.06 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | -0.8218 x |
| Free Cash Flow 1 | 0.16 | -0.18 | -1.05 | -0.64 | -0.21 | -0.19 |
| ROE (net income / shareholders' equity) | -33.2% | -14.6% | -143% | -93.7% | -173% | 240% |
| ROA (Net income/ Total Assets) | -10.7% | -7.22% | -27% | -36.2% | -33.7% | -57.5% |
| Assets 1 | 5.662 | 6.979 | 13.46 | 3.299 | 1.903 | 0.9158 |
| Book Value Per Share 2 | 0.0700 | 0.0600 | 0.0300 | 0.0100 | 0 | -0.0100 |
| Cash Flow per Share 2 | 0.0800 | 0.0700 | 0.0300 | 0.0100 | 0.0100 | 0 |
| Capex | - | - | 0.19 | 0.01 | - | 0 |
| Capex / Sales | - | - | 125.6% | 10.57% | - | 0.8% |
| Announcement Date | 2/22/19 | 1/24/20 | 4/30/21 | 2/28/22 | 2/28/23 | 2/28/24 |
1GBP in Million2GBP
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
- Stock Market
- Equities
- AIQ Stock
- Financials AIQ
